{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:13:03Z","timestamp":1769854383630,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.rbmo.2020.06.004","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T11:30:47Z","timestamp":1592220647000},"page":"357-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Trends in ovarian hyperstimulation syndrome hospitalization rates in the USA: an ongoing concern"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3070-8619","authenticated-orcid":false,"given":"Keren","family":"Rotshenker-Olshinka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Badeghiesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Volodarsky-Perel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naama","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Suarthana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.rbmo.2020.06.004_bib0001","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.rbmo.2020.06.004_bib0002","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2007-0409","article-title":"Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction","volume":"92","author":"\u00c1lvarez","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2020.06.004_bib0003","first-page":"1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial","volume":"15","author":"Borm","year":"2000","journal-title":"The European Orgalutran Study Group. Hum. Reprod."},{"key":"10.1016\/j.rbmo.2020.06.004_bib0004","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/humrep\/dew151","article-title":"Assisted reproductive technology in Europe, 2012: Results generated from European registers by ESHRE","volume":"31","author":"Calhaz-Jorge","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2020.06.004_bib0005","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review","volume":"8","author":"Delvinge","year":"2002","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2020.06.004_bib0006","first-page":"1","article-title":"ART in Europe, 2015: results generated from European registries by ESHRE","author":"Geyter","year":"2020","journal-title":"Hum. Reprod. Open"},{"key":"10.1016\/j.rbmo.2020.06.004_bib0007","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2020.06.004_bib0008","unstructured":"H-CUP, 2019. Overview of the National (Nationwide) Inpatient Sample (NIS) [WWW Document]. URLhttps:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp"},{"key":"10.1016\/j.rbmo.2020.06.004_bib0009","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jama.2014.14488","article-title":"Safety of Assisted Reproductive Technology in the United States, 2000-2011","volume":"313","author":"Kawwass","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.rbmo.2020.06.004_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/PL00007479","article-title":"Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction","volume":"264","author":"Ludwig","year":"2000","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.rbmo.2020.06.004_bib0011","article-title":"Interventions for the prevention of OHSS in ART cycles: An overview of Cochrane reviews","volume":"2017","author":"Mourad","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rbmo.2020.06.004_bib0012","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.fertnstert.2016.08.048","article-title":"Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline","volume":"106","author":"Pfeifer","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2020.06.004_bib0013","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10815-018-1372-5","article-title":"Rare genetic variants potentially involved in ovarian hyperstimulation syndrome","volume":"36","author":"Stouffs","year":"2019","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2020.06.004_bib0014","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","article-title":"The use of metformin for women with PCOS undergoing IVF treatment","volume":"21","author":"Tang","year":"2006","journal-title":"Hum. Reprod."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320303291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648320303291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:19:53Z","timestamp":1761466793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648320303291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1472648320303291"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.06.004","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in ovarian hyperstimulation syndrome hospitalization rates in the USA: an ongoing concern","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2020.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}